OTCQB: LXXGF | TSX.V: LXG

  • Company
    • Our Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
    • Join Our Team
    • News Releases
    • In the Media
    • Upcoming Events
  • Investors
    • Presentations
    • Financials
    • Share Structure
    • Stock Information
    • Investor Events
    • Investor Inquiries
  • Markets
    • Biologics Manufacturing
    • Veterinary Diagnostics
  • Products
    • MiQLab® System
    • Assay Panels
    • Request Product Information
    • I’d Like a Demonstration
  • Resources
  • Our Blog
  • Contact
    • Contact
    • Investor Inquiries
    • Support
    • Product Information
    • Subscribe for Updates
Read Dr Jack Regan on Pandemic Prevention with Better Diagnostics

Read Dr Jack Regan on Pandemic Prevention with Better Diagnostics

by LexaGene | Jun 15, 2021 | Biologics Manufacturing

Writing in Clinical Lab Products Magazine, Dr Jack Regan makes a strong case that diagnostic technology investment is key to preventing future pandemic diseases.

Cleanroom Technology on Cannabis Testing

Cleanroom Technology on Cannabis Testing

by LexaGene | Jan 21, 2021 | Biologics Manufacturing

Shortcomings in traditional culture testing leave the cannabis industry in search of methods that can enumerate or count the presence of microbes whether dead or alive.

Roundtable: Frontline Genomics

Roundtable: Frontline Genomics

by LexaGene | Nov 15, 2017 | Biologics Manufacturing

LexaGene’s CEO Jack Regan was featured in a roundtable for Frontline Genomics Magazine on infectious disease control.

Press Releases

  • The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants February 6, 2023
  • Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology May 25, 2022
  • The Dawn of the Superbugs May 10, 2022
  • LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility April 7, 2022
  • Bacterial Culture: Is It Time to Rethink the Gold Standard? March 28, 2022

Categories

  • Biologics Manufacturing
  • Biothreat Detection
  • Human Clinical Diagnostics
  • Investor Information
  • Product Information
  • Veterinary Diagnostics
  • Contact
  • Support
  • Privacy
  • Terms
  • Site Map

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA
info@lexagene.com | 800.215.1824

Subscribe for Updates
  • Follow
  • Follow
  • Follow
  • Follow

©2022 LexaGene All Rights Reserved